OnQ Pain Pump Effectiveness in Post Operative Pain Control in Bariatric Patients

Status

Withdrawn

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03159130

Enrollment

Registered

2017-05-18

Start date

2012-06-30

Completion date

2014-06-30

Last updated

2017-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Morbid Obesity

Keywords

Pain pump catheters, bariatric surgery, OnQ pump, sleeve gastrectomy, continuous infusion catheter

Brief summary

This study will assess the efficacy of OnQ pain catheters in pain reduction in the bariatric surgical population and seeks to identify if a quantifiable improved post-operative course occurs in patients receiving a catheter filled with local anesthetic versus that achieved by patients who receive a catheter filled with injectable saline.

Detailed description

This study will assess the efficacy of OnQ pain catheters in pain reduction in the bariatric surgical population. Approximately 12 to 15 weight reduction surgeries are performed at William Beaumont Army Medical Center each month. It is the current practice that each patient receiving the laparoscopic gastric sleeve or laparoscopic Roux-en-Y gastric bypass receive an OnQ pain catheter during the surgery to reduce post-operative pain. There have been limited studies to quantify the efficacy of these devices. This study will seek to identify if a quantifiable improved post-operative course occurs in patients receiving a catheter filled with local anesthetic versus that achieved by patients who receive a catheter filled with injectable saline.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

* Meets criteria for Bariatric surgery * Consents to be in protocol * No local anesthetic allergy * Will be having sleeve gastrectomy * Doesn't have extensive scarring of abdominal wall that would prevent placement of OnQ catheter

Exclusion criteria

* declines to participate

Design outcomes

Primary

Measure	Time frame	Description
Narcotic use	from admission to recovery room until discharge from the hospital (3-5 days)	immediate post-operative narcotic use per patient

Countries

United States

Outcome results